Edgestream Partners L.P. bought a new position in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor bought 19,015 shares of the industrial products company’s stock, valued at approximately $1,084,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of PRLB. Group One Trading LLC acquired a new stake in Proto Labs in the 4th quarter valued at about $25,000. NewEdge Advisors LLC grew its stake in shares of Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 738 shares during the last quarter. NBC Securities Inc. bought a new stake in shares of Proto Labs in the 4th quarter worth approximately $46,000. Modus Advisors LLC bought a new stake in shares of Proto Labs in the 4th quarter worth approximately $57,000. Finally, Aquatic Capital Management LLC acquired a new stake in Proto Labs during the third quarter valued at approximately $64,000. 84.54% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Wall Street Zen cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Needham & Company LLC upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective for the company in a research report on Monday. Weiss Ratings raised Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, July 17th. Benchmark raised their price objective on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Finally, Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a report on Friday, July 3rd. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $89.00.
Proto Labs Stock Up 7.4%
Shares of NYSE:PRLB opened at $80.58 on Tuesday. The company’s fifty day moving average is $77.18 and its two-hundred day moving average is $66.97. Proto Labs, Inc. has a 12-month low of $42.84 and a 12-month high of $83.15. The company has a market cap of $1.92 billion, a P/E ratio of 64.47 and a beta of 1.38.
Proto Labs (NYSE:PRLB – Get Free Report) last issued its earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The business had revenue of $149.34 million during the quarter, compared to analysts’ expectations of $144.53 million. During the same quarter last year, the firm posted $0.41 earnings per share. Proto Labs’s revenue was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Equities research analysts anticipate that Proto Labs, Inc. will post 1.37 earnings per share for the current year.
Insider Activity
In related news, insider Michael R. Kenison sold 16,030 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total value of $1,113,924.70. Following the completion of the sale, the insider directly owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. This represents a 46.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director owned 32,505 shares of the company’s stock, valued at $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 25,663 shares of company stock valued at $1,804,727. Company insiders own 1.30% of the company’s stock.
About Proto Labs
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
See Also
- Five stocks we like better than Proto Labs
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
